Valo Stock
HealthTechLooking to sell Valo stock or options?
Valo is a health tech platform developer dedicated to streamlining the process of drug discovery and development. The platform leverages machine learning, cloud computing, and data to examine human data, revealing unexpected connections between genetic markers and disease through a human-focused lens. This enables healthcare industry clients to formulate drugs for oncology, neurodegenerative, and cardiovascular diseases.
HBM Healthcare Investments, MissionBlue Capital Partners, Hercules Capital, Atinum Investment, Public Sector Pension Investment Board, E Squared Capital Management, The Invus Group, HBM Partners, Municipal Employees' Retirement System of Michigan, Flagship Pioneering, InterWest Partners, Lanza techVentures, Longevity Vision Fund, Mercury Fund, Mirae Asset Capital, Koch Disruptive Technologies.